Placebo furosemide

DRUG2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Bayer

Conditions

Acute Myocardial Infarction With Right Ventricular ExtensionHeart Failure (HF)

Phase 2

A Trial to Study BAY1753011 in Patients With Congestive Heart Failure

CompletedNCT03901729

BayerHeart Failure (HF)

Start: 2019-05-29End: 2021-05-21Updated: 2022-04-18

Phase 3

Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction

Assistance Publique - Hôpitaux de ParisAcute Myocardial Infarction With Right Ventricular Extension

Start: 2016-12-31End: 2019-01-31Target: 88Updated: 2016-09-19

Related Papers

A multicentre, randomized, double‐blind, active and placebo‐controlled study of pecavaptan, a dual V1a/ <scp>V2</scp> vasopressin receptor antagonist, in patients with acute heart failure: The <scp>AVANTI</scp> trial

European Journal of Heart Failure2025-08-11

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.

2020-10-2416 citations

Intravenous Iron Therapy for Patients with Heart Failure: Expanding Body of Evidence

ESC Heart Failure2019-07-165 citations